Skip Navigation LinksHome > December 2010 - Volume 4 - Issue 4 > Patients' Reasons for Choosing Office-Based Buprenorphine: P...
Journal of Addiction Medicine:
doi: 10.1097/ADM.0b013e3181cc9610
Original Article

Patients' Reasons for Choosing Office-Based Buprenorphine: Preference for Patient-Centered Care

Korthuis, P. Todd MD, MPH; Gregg, Jessica MD, PhD; Rogers, Wendy E. MS; McCarty, Dennis PhD; Nicolaidis, Christina MD, MPH; Boverman, Joshua MD

Collapse Box

Abstract

Objectives: To explore human immunodeficiency virus (HIV)-infected patients' attitudes about buprenorphine treatment in office-based and opioid treatment program (OTP) settings.

Methods: We conducted in-depth qualitative interviews with 29 patients with coexisting HIV infection and opioid dependence seeking buprenorphine maintenance therapy in office-based and OTP settings. We used thematic analysis of transcribed audiorecorded interviews to identify themes.

Results: Patients voiced a strong preference for office-based treatment. Four themes emerged to explain this preference. First, patients perceived the greater convenience of office-based treatment as improving their ability to address HIV and other healthcare issues. Second, they perceived a strong patient-focused orientation in patient-provider relationships, underpinning their preference for office-based care. This was manifested as increased trust, listening, empathy, and respect from office-based staff and providers. Third, they perceived shared power and responsibility in office-based settings. Finally, patients viewed office-based treatment as a more supportive environment for sobriety and relapse prevention. This was, in part, due to strong therapeutic alliances with office-based staff and providers who prioritized a harm reduction approach and also the perception that the office-based settings were “safer” for sobriety, compared with increased opportunities for purchasing and using illicit opiates in OTP settings.

Conclusions: HIV-infected patients with opioid dependence preferred office-based buprenorphine, because they perceived it as offering a more patient-centered approach to care compared with OTP referral. Office-based buprenorphine may facilitate engagement in care for patients with coexisting opioid dependence and HIV infection.

© 2010 American Society of Addiction Medicine

    

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.